Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of centriole replication (GO:0046599) | 9.83757223 |
2 | coronary vasculature morphogenesis (GO:0060977) | 9.63209025 |
3 | lung lobe morphogenesis (GO:0060463) | 9.60240042 |
4 | auditory receptor cell stereocilium organization (GO:0060088) | 8.63411170 |
5 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 8.02930478 |
6 | phospholipid scrambling (GO:0017121) | 7.81761430 |
7 | cellular response to ATP (GO:0071318) | 7.53979718 |
8 | regulation of skeletal muscle contraction (GO:0014819) | 7.49452027 |
9 | protein targeting to plasma membrane (GO:0072661) | 7.39517664 |
10 | negative regulation of cell aging (GO:0090344) | 7.34975684 |
11 | glial cell migration (GO:0008347) | 7.08754865 |
12 | negative regulation of protein localization to cell surface (GO:2000009) | 7.03065188 |
13 | peptidyl-glutamic acid carboxylation (GO:0017187) | 7.01278426 |
14 | protein carboxylation (GO:0018214) | 7.01278426 |
15 | galactose catabolic process (GO:0019388) | 6.76888542 |
16 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 6.74597820 |
17 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 6.69381918 |
18 | mitotic cell cycle arrest (GO:0071850) | 6.51229798 |
19 | GDP-mannose metabolic process (GO:0019673) | 6.37035881 |
20 | vesicle fusion (GO:0006906) | 6.34457974 |
21 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 6.32172604 |
22 | DNA strand renaturation (GO:0000733) | 6.23443536 |
23 | adenosine receptor signaling pathway (GO:0001973) | 6.17833751 |
24 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 6.15366140 |
25 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 6.01606149 |
26 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 5.96518797 |
27 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 5.96487551 |
28 | regulation of synapse structural plasticity (GO:0051823) | 5.91670656 |
29 | inner ear receptor stereocilium organization (GO:0060122) | 5.70322229 |
30 | lens fiber cell differentiation (GO:0070306) | 5.70101151 |
31 | negative regulation of telomerase activity (GO:0051974) | 5.68834961 |
32 | regulation of dendritic spine morphogenesis (GO:0061001) | 5.59404845 |
33 | postsynaptic membrane organization (GO:0001941) | 5.55046159 |
34 | transepithelial transport (GO:0070633) | 5.48908440 |
35 | keratan sulfate catabolic process (GO:0042340) | 5.48398880 |
36 | detection of light stimulus involved in visual perception (GO:0050908) | 5.47689897 |
37 | detection of light stimulus involved in sensory perception (GO:0050962) | 5.47689897 |
38 | negative regulation of DNA biosynthetic process (GO:2000279) | 5.47607779 |
39 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 5.47044121 |
40 | negative regulation of interleukin-2 production (GO:0032703) | 5.37729531 |
41 | meiotic chromosome segregation (GO:0045132) | 5.33197728 |
42 | interferon-gamma production (GO:0032609) | 5.24823120 |
43 | response to ATP (GO:0033198) | 4.94072530 |
44 | negative regulation of interleukin-8 production (GO:0032717) | 4.90503766 |
45 | anatomical structure maturation (GO:0071695) | 4.87393705 |
46 | polarized epithelial cell differentiation (GO:0030859) | 4.85584862 |
47 | positive regulation of establishment of protein localization to plasma membrane (GO:0090004) | 4.73664715 |
48 | presynaptic membrane assembly (GO:0097105) | 4.71992177 |
49 | positive regulation of dendritic spine development (GO:0060999) | 4.69377168 |
50 | detection of molecule of bacterial origin (GO:0032490) | 4.62305992 |
51 | tachykinin receptor signaling pathway (GO:0007217) | 4.62158403 |
52 | positive regulation of protein localization to plasma membrane (GO:1903078) | 4.55582896 |
53 | purinergic receptor signaling pathway (GO:0035587) | 4.55029919 |
54 | granulocyte differentiation (GO:0030851) | 4.50818807 |
55 | neuron projection regeneration (GO:0031102) | 4.39575667 |
56 | mannose metabolic process (GO:0006013) | 4.38595582 |
57 | positive regulation of heat generation (GO:0031652) | 4.37347432 |
58 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 4.31986809 |
59 | COPII vesicle coating (GO:0048208) | 4.27191378 |
60 | short-term memory (GO:0007614) | 4.25999161 |
61 | phosphatidylglycerol biosynthetic process (GO:0006655) | 4.13867267 |
62 | vocalization behavior (GO:0071625) | 4.12843270 |
63 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 4.11881609 |
64 | regulation of dendritic spine development (GO:0060998) | 4.09510120 |
65 | regulation of establishment of planar polarity (GO:0090175) | 4.02399394 |
66 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.01356001 |
67 | cornea development in camera-type eye (GO:0061303) | 3.97221227 |
68 | sensory perception of taste (GO:0050909) | 3.96687953 |
69 | aorta morphogenesis (GO:0035909) | 3.96659386 |
70 | response to gravity (GO:0009629) | 3.94926575 |
71 | estrogen biosynthetic process (GO:0006703) | 3.88912654 |
72 | regulation of centrosome duplication (GO:0010824) | 3.80399365 |
73 | sphingomyelin metabolic process (GO:0006684) | 3.78092536 |
74 | negative regulation of fibroblast apoptotic process (GO:2000270) | 3.76621550 |
75 | cellular response to estradiol stimulus (GO:0071392) | 3.74107804 |
76 | positive regulation of protein kinase C signaling (GO:0090037) | 3.71861391 |
77 | presynaptic membrane organization (GO:0097090) | 3.71732655 |
78 | rRNA methylation (GO:0031167) | 3.67729819 |
79 | semaphorin-plexin signaling pathway (GO:0071526) | 3.64756967 |
80 | sphingosine metabolic process (GO:0006670) | 3.58548416 |
81 | oligosaccharide catabolic process (GO:0009313) | 3.53451850 |
82 | phagocytosis, engulfment (GO:0006911) | 3.52624553 |
83 | cardiolipin metabolic process (GO:0032048) | 3.49341768 |
84 | positive thymic T cell selection (GO:0045059) | 3.49182990 |
85 | regulation of phospholipid biosynthetic process (GO:0071071) | 3.41045008 |
86 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 3.38482206 |
87 | epithelial cell fate commitment (GO:0072148) | 3.36099691 |
88 | diol metabolic process (GO:0034311) | 3.34135279 |
89 | negative regulation of smooth muscle cell differentiation (GO:0051151) | 3.34009754 |
90 | oligodendrocyte differentiation (GO:0048709) | 3.33019203 |
91 | response to peptidoglycan (GO:0032494) | 3.32315866 |
92 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.31146198 |
93 | galactose metabolic process (GO:0006012) | 3.30555497 |
94 | sympathetic nervous system development (GO:0048485) | 3.30202735 |
95 | detection of external biotic stimulus (GO:0098581) | 3.26754423 |
96 | positive regulation of vascular permeability (GO:0043117) | 3.26578420 |
97 | regulation of membrane lipid distribution (GO:0097035) | 3.22360144 |
98 | UV protection (GO:0009650) | 3.21639703 |
99 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 3.21187677 |
100 | neuronal action potential (GO:0019228) | 3.19890417 |
101 | histone phosphorylation (GO:0016572) | 3.18124555 |
102 | dendrite development (GO:0016358) | 3.16187677 |
103 | regulation of heat generation (GO:0031650) | 3.16140941 |
104 | positive T cell selection (GO:0043368) | 3.15739834 |
105 | cellular anion homeostasis (GO:0030002) | 3.15058706 |
106 | neuron cell-cell adhesion (GO:0007158) | 3.11085040 |
107 | asymmetric protein localization (GO:0008105) | 3.09280202 |
108 | regulation of cell aging (GO:0090342) | 3.09051714 |
109 | negative regulation of JAK-STAT cascade (GO:0046426) | 3.08387526 |
110 | urinary tract smooth muscle contraction (GO:0014848) | 3.06817514 |
111 | response to muramyl dipeptide (GO:0032495) | 3.06762498 |
112 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 3.05666403 |
113 | histone H3-K36 demethylation (GO:0070544) | 3.03837960 |
114 | behavioral response to nicotine (GO:0035095) | 3.03505865 |
115 | urogenital system development (GO:0001655) | 3.02576781 |
116 | sodium ion homeostasis (GO:0055078) | 3.01431743 |
117 | trivalent inorganic anion homeostasis (GO:0072506) | 3.00992053 |
118 | phosphate ion homeostasis (GO:0055062) | 3.00992053 |
119 | mitochondrion distribution (GO:0048311) | 3.00500589 |
120 | mast cell degranulation (GO:0043303) | 3.00019334 |
121 | mast cell activation involved in immune response (GO:0002279) | 3.00019334 |
122 | purine ribonucleotide transport (GO:0015868) | 2.96979482 |
123 | plasma membrane repair (GO:0001778) | 2.96947306 |
124 | peristalsis (GO:0030432) | 2.96886780 |
125 | negative regulation of activin receptor signaling pathway (GO:0032926) | 2.95760297 |
126 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.95090509 |
127 | myelin maintenance (GO:0043217) | 2.94787218 |
128 | regulation of telomerase activity (GO:0051972) | 2.92433561 |
129 | negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394) | 2.92274305 |
130 | peptidyl-glutamic acid modification (GO:0018200) | 2.91261006 |
131 | peripheral nervous system development (GO:0007422) | 2.89062157 |
132 | regulation of activin receptor signaling pathway (GO:0032925) | 2.88768191 |
133 | sulfur amino acid catabolic process (GO:0000098) | 2.88635397 |
134 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.88156780 |
135 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.88049296 |
136 | endocytic recycling (GO:0032456) | 2.87886199 |
137 | inositol phosphate-mediated signaling (GO:0048016) | 2.87816153 |
138 | positive regulation of dendrite morphogenesis (GO:0050775) | 2.86742740 |
139 | sleep (GO:0030431) | 2.85825965 |
140 | detection of biotic stimulus (GO:0009595) | 2.85007805 |
141 | establishment of protein localization to plasma membrane (GO:0090002) | 2.84132831 |
142 | membrane assembly (GO:0071709) | 2.83559970 |
143 | regulation of centrosome cycle (GO:0046605) | 2.83019108 |
144 | cellular response to electrical stimulus (GO:0071257) | 2.79061224 |
145 | phosphatidylethanolamine metabolic process (GO:0046337) | 2.78519721 |
146 | atrial septum morphogenesis (GO:0060413) | 2.77436809 |
147 | membrane depolarization during action potential (GO:0086010) | 2.75764478 |
148 | rRNA modification (GO:0000154) | 2.75557770 |
149 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 2.74780771 |
150 | regulation of dendrite morphogenesis (GO:0048814) | 2.74021372 |
151 | cellular response to gonadotropin stimulus (GO:0071371) | 2.73396581 |
152 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.72237522 |
153 | grooming behavior (GO:0007625) | 2.70920819 |
154 | regulation of fibroblast apoptotic process (GO:2000269) | 2.70443590 |
155 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.69735460 |
156 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436) | 2.69682748 |
157 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.69455622 |
158 | positive regulation of interferon-alpha production (GO:0032727) | 2.67786004 |
159 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.67091497 |
160 | nucleotide transmembrane transport (GO:1901679) | 2.66523398 |
161 | male sex determination (GO:0030238) | 2.65942887 |
162 | sialylation (GO:0097503) | 2.65271298 |
163 | cellular extravasation (GO:0045123) | 2.63918019 |
164 | regulation of interferon-beta production (GO:0032648) | 2.63524597 |
165 | peripheral nervous system axon ensheathment (GO:0032292) | 2.62208114 |
166 | myelination in peripheral nervous system (GO:0022011) | 2.62208114 |
167 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.61746611 |
168 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 2.59778609 |
169 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 2.59778609 |
170 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.59309305 |
171 | muscle cell fate commitment (GO:0042693) | 2.58877040 |
172 | mast cell activation (GO:0045576) | 2.58873035 |
173 | regulation of establishment of protein localization to plasma membrane (GO:0090003) | 2.58294973 |
174 | histone H4 deacetylation (GO:0070933) | 2.58210036 |
175 | adenine nucleotide transport (GO:0051503) | 2.57880152 |
176 | negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736) | 2.57800125 |
177 | phosphate ion transmembrane transport (GO:0035435) | 2.57425346 |
178 | regulation of guanylate cyclase activity (GO:0031282) | 2.57269032 |
179 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.56924502 |
180 | sex determination (GO:0007530) | 2.56509886 |
181 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.56216046 |
182 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.56216046 |
183 | positive regulation of proteasomal protein catabolic process (GO:1901800) | 2.56118587 |
184 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.56055191 |
185 | membrane invagination (GO:0010324) | 2.55269989 |
186 | sphingoid metabolic process (GO:0046519) | 2.51583030 |
187 | negative regulation of TOR signaling (GO:0032007) | 2.49398910 |
188 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.48894538 |
189 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.48894538 |
190 | type B pancreatic cell proliferation (GO:0044342) | 2.48831369 |
191 | myeloid cell activation involved in immune response (GO:0002275) | 2.47141307 |
192 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.46819371 |
193 | melanin metabolic process (GO:0006582) | 2.45519040 |
194 | regulation of interferon-alpha production (GO:0032647) | 2.44870383 |
195 | leukocyte degranulation (GO:0043299) | 2.39049302 |
196 | blood vessel maturation (GO:0001955) | 11.4276998 |
197 | tooth mineralization (GO:0034505) | 10.7459694 |
Rank | Gene Set | Z-score |
---|---|---|
1 | VDR_21846776_ChIP-Seq_THP-1_Human | 4.98740148 |
2 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 4.41280444 |
3 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.52880224 |
4 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.46229650 |
5 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.26642351 |
6 | TP53_16413492_ChIP-PET_HCT116_Human | 3.14959940 |
7 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.04619569 |
8 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.86489806 |
9 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.83935064 |
10 | * MAF_26560356_Chip-Seq_TH2_Human | 2.80763806 |
11 | P68_20966046_ChIP-Seq_HELA_Human | 2.78321549 |
12 | * MAF_26560356_Chip-Seq_TH1_Human | 2.59953829 |
13 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.53198681 |
14 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.53198681 |
15 | MYC_22102868_ChIP-Seq_BL_Human | 2.51166427 |
16 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.36222512 |
17 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.33930381 |
18 | BCL6_27268052_Chip-Seq_Bcells_Human | 2.26811806 |
19 | BCOR_27268052_Chip-Seq_Bcells_Human | 2.25543523 |
20 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.23907053 |
21 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.23636723 |
22 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.23460556 |
23 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.22876692 |
24 | E2F1_20622854_ChIP-Seq_HELA_Human | 2.21107729 |
25 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.20963851 |
26 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.18573073 |
27 | UTX_26944678_Chip-Seq_JUKART_Human | 2.16942757 |
28 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.14061547 |
29 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.12584882 |
30 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.12522588 |
31 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.08589663 |
32 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.07643437 |
33 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 2.05285334 |
34 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.04266968 |
35 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 2.01580507 |
36 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.98002156 |
37 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.97016104 |
38 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.96949244 |
39 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.96909643 |
40 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.94408600 |
41 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.93908941 |
42 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.92712600 |
43 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.90506449 |
44 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.89979925 |
45 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.87806273 |
46 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.87540570 |
47 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.85707969 |
48 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.85238311 |
49 | * MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.84242335 |
50 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.81477484 |
51 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.78330061 |
52 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.77967270 |
53 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.73988446 |
54 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.71511641 |
55 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.71153906 |
56 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.69248396 |
57 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.69132276 |
58 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.67996454 |
59 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.67106399 |
60 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.66338341 |
61 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.64542803 |
62 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.63823950 |
63 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.63002649 |
64 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.62066520 |
65 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.60238383 |
66 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.60169015 |
67 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.59929034 |
68 | * SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.59431156 |
69 | CJUN_26792858_Chip-Seq_BT549_Human | 1.57821437 |
70 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.57124799 |
71 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.56833163 |
72 | KDM2B_26808549_Chip-Seq_K562_Human | 1.56439369 |
73 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.55219599 |
74 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.54798102 |
75 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.54400051 |
76 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.53614179 |
77 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.52377242 |
78 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.52121977 |
79 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.50459934 |
80 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.49719340 |
81 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.49221797 |
82 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.46301425 |
83 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.45714670 |
84 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.43959712 |
85 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.43209172 |
86 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.42653851 |
87 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.42310209 |
88 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.42294695 |
89 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.41713413 |
90 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.41497001 |
91 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.41295754 |
92 | GATA1_19941826_ChIP-Seq_K562_Human | 1.40806437 |
93 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.37685427 |
94 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.37603733 |
95 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.36576888 |
96 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.36162811 |
97 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.35205211 |
98 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.35152113 |
99 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.34719947 |
100 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.34417828 |
101 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.34255443 |
102 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.33759223 |
103 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.33170871 |
104 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.32252075 |
105 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.32210484 |
106 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.31099954 |
107 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.30291156 |
108 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.29636502 |
109 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.29049732 |
110 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.28946449 |
111 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.28855276 |
112 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.28283489 |
113 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.28246099 |
114 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.27052192 |
115 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.25796843 |
116 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.25777275 |
117 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.23691339 |
118 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.22870474 |
119 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22766451 |
120 | P300_27268052_Chip-Seq_Bcells_Human | 1.22695996 |
121 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.22568207 |
122 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.21486571 |
123 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.21420006 |
124 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21372526 |
125 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.21324485 |
126 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.19867006 |
127 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.19632851 |
128 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.19025503 |
129 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18905097 |
130 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18692284 |
131 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.17498880 |
132 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.16915990 |
133 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.16075175 |
134 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.15688415 |
135 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.15375197 |
136 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.15024908 |
137 | FLI1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.14588221 |
138 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14254289 |
139 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.13259646 |
140 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.12683075 |
141 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12037242 |
142 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.10477194 |
143 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.09948656 |
144 | ERA_21632823_ChIP-Seq_H3396_Human | 1.08871883 |
145 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.08183244 |
146 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.08175421 |
147 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.06890139 |
148 | SA1_27219007_Chip-Seq_Bcells_Human | 1.06552711 |
149 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.05788795 |
150 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.05249963 |
151 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.04705932 |
152 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.04613437 |
153 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.04425581 |
154 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.04132674 |
155 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04046330 |
156 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.03089538 |
157 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.03041904 |
158 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.02907738 |
159 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.02869140 |
160 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.02641149 |
161 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02285945 |
162 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02139296 |
163 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.00694572 |
164 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.00495045 |
165 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.00173544 |
166 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.99479253 |
167 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.99210332 |
168 | SPI1_23127762_ChIP-Seq_K562_Human | 0.98960349 |
169 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.98907960 |
170 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.98722287 |
171 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.98632263 |
172 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.98076988 |
173 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.95173498 |
174 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.94785325 |
175 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.94020459 |
176 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.94018128 |
177 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.90562861 |
178 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.89777518 |
179 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.88069205 |
180 | PPARD_21283829_ChIP-Seq_MYOFIBROBLAST_Human | 0.86438890 |
181 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.86189009 |
182 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.85302735 |
183 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.84269166 |
184 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.83763350 |
185 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.80687448 |
186 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.80082216 |
187 | AR_19668381_ChIP-Seq_PC3_Human | 0.79434967 |
188 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.79305064 |
189 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.78941038 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001986_abnormal_taste_sensitivity | 6.82647341 |
2 | MP0005171_absent_coat_pigmentation | 6.64648470 |
3 | MP0005174_abnormal_tail_pigmentation | 5.80527407 |
4 | MP0004272_abnormal_basement_membrane | 5.71084030 |
5 | MP0002837_dystrophic_cardiac_calcinosis | 5.54367156 |
6 | MP0009780_abnormal_chondrocyte_physiolo | 4.98120010 |
7 | MP0005423_abnormal_somatic_nervous | 4.09749437 |
8 | MP0003724_increased_susceptibility_to | 4.05744888 |
9 | MP0003045_fibrosis | 3.73681654 |
10 | MP0003136_yellow_coat_color | 3.42474372 |
11 | MP0005409_darkened_coat_color | 3.39746440 |
12 | MP0005076_abnormal_cell_differentiation | 3.05227026 |
13 | MP0008875_abnormal_xenobiotic_pharmacok | 2.92317217 |
14 | MP0001348_abnormal_lacrimal_gland | 2.89235060 |
15 | MP0008260_abnormal_autophagy | 2.87052716 |
16 | MP0003705_abnormal_hypodermis_morpholog | 2.77599878 |
17 | MP0003690_abnormal_glial_cell | 2.77081577 |
18 | MP0000751_myopathy | 2.64548768 |
19 | MP0001188_hyperpigmentation | 2.63940478 |
20 | MP0000015_abnormal_ear_pigmentation | 2.51228694 |
21 | MP0001529_abnormal_vocalization | 2.47397454 |
22 | MP0005083_abnormal_biliary_tract | 2.45746005 |
23 | MP0001756_abnormal_urination | 2.28329962 |
24 | MP0004147_increased_porphyrin_level | 2.11388231 |
25 | MP0003453_abnormal_keratinocyte_physiol | 2.07444647 |
26 | MP0001661_extended_life_span | 2.04791783 |
27 | MP0001486_abnormal_startle_reflex | 2.00731729 |
28 | MP0001984_abnormal_olfaction | 1.99561765 |
29 | MP0003137_abnormal_impulse_conducting | 1.91169122 |
30 | MP0002909_abnormal_adrenal_gland | 1.88779477 |
31 | MP0004859_abnormal_synaptic_plasticity | 1.84647434 |
32 | MP0004130_abnormal_muscle_cell | 1.82866205 |
33 | MP0003011_delayed_dark_adaptation | 1.81977124 |
34 | MP0003172_abnormal_lysosome_physiology | 1.79065891 |
35 | MP0005645_abnormal_hypothalamus_physiol | 1.75988809 |
36 | MP0002653_abnormal_ependyma_morphology | 1.73682240 |
37 | MP0008961_abnormal_basal_metabolism | 1.63569694 |
38 | MP0005365_abnormal_bile_salt | 1.61347730 |
39 | MP0000678_abnormal_parathyroid_gland | 1.61327425 |
40 | MP0003436_decreased_susceptibility_to | 1.60157838 |
41 | MP0010368_abnormal_lymphatic_system | 1.59451151 |
42 | MP0000538_abnormal_urinary_bladder | 1.59302965 |
43 | MP0003385_abnormal_body_wall | 1.57593216 |
44 | MP0002638_abnormal_pupillary_reflex | 1.52739670 |
45 | MP0005058_abnormal_lysosome_morphology | 1.52122227 |
46 | MP0001919_abnormal_reproductive_system | 1.47386827 |
47 | MP0003634_abnormal_glial_cell | 1.46091676 |
48 | MP0001765_abnormal_ion_homeostasis | 1.43154424 |
49 | MP0002168_other_aberrant_phenotype | 1.42732939 |
50 | MP0000920_abnormal_myelination | 1.42319933 |
51 | MP0008438_abnormal_cutaneous_collagen | 1.41799276 |
52 | MP0001502_abnormal_circadian_rhythm | 1.41048872 |
53 | MP0001835_abnormal_antigen_presentation | 1.40173621 |
54 | MP0002751_abnormal_autonomic_nervous | 1.39632602 |
55 | MP0001849_ear_inflammation | 1.39573658 |
56 | MP0002160_abnormal_reproductive_system | 1.38077300 |
57 | MP0003943_abnormal_hepatobiliary_system | 1.36844755 |
58 | MP0005166_decreased_susceptibility_to | 1.36778158 |
59 | MP0001340_abnormal_eyelid_morphology | 1.33392866 |
60 | MP0001968_abnormal_touch/_nociception | 1.32602380 |
61 | MP0005410_abnormal_fertilization | 1.27918279 |
62 | MP0000749_muscle_degeneration | 1.26881767 |
63 | MP0006082_CNS_inflammation | 1.25306741 |
64 | MP0009840_abnormal_foam_cell | 1.21552112 |
65 | MP0010155_abnormal_intestine_physiology | 1.18945976 |
66 | MP0003091_abnormal_cell_migration | 1.18618853 |
67 | MP0003763_abnormal_thymus_physiology | 1.17704250 |
68 | MP0000750_abnormal_muscle_regeneration | 1.17036710 |
69 | MP0001800_abnormal_humoral_immune | 1.16657933 |
70 | MP0009278_abnormal_bone_marrow | 1.16148621 |
71 | MP0002723_abnormal_immune_serum | 1.13293379 |
72 | MP0009384_cardiac_valve_regurgitation | 1.13230782 |
73 | MP0005386_behavior/neurological_phenoty | 1.11723302 |
74 | MP0004924_abnormal_behavior | 1.11723302 |
75 | MP0002557_abnormal_social/conspecific_i | 1.09491083 |
76 | MP0002933_joint_inflammation | 1.09113891 |
77 | MP0002452_abnormal_antigen_presenting | 1.08767564 |
78 | MP0005501_abnormal_skin_physiology | 1.08451703 |
79 | MP0005332_abnormal_amino_acid | 1.07509171 |
80 | MP0000470_abnormal_stomach_morphology | 1.06022301 |
81 | MP0002063_abnormal_learning/memory/cond | 1.04607597 |
82 | MP0001873_stomach_inflammation | 1.03696088 |
83 | MP0005084_abnormal_gallbladder_morpholo | 1.01095727 |
84 | MP0005025_abnormal_response_to | 1.00450116 |
85 | MP0002398_abnormal_bone_marrow | 1.00372132 |
86 | MP0004381_abnormal_hair_follicle | 0.99660054 |
87 | MP0000685_abnormal_immune_system | 0.98923670 |
88 | MP0003806_abnormal_nucleotide_metabolis | 0.98293896 |
89 | MP0003566_abnormal_cell_adhesion | 0.98234573 |
90 | MP0000013_abnormal_adipose_tissue | 0.97714552 |
91 | MP0002420_abnormal_adaptive_immunity | 0.96367422 |
92 | MP0002419_abnormal_innate_immunity | 0.96340170 |
93 | MP0001533_abnormal_skeleton_physiology | 0.96013277 |
94 | MP0001819_abnormal_immune_cell | 0.95518151 |
95 | MP0002009_preneoplasia | 0.95480341 |
96 | MP0004858_abnormal_nervous_system | 0.93671579 |
97 | MP0002064_seizures | 0.92734732 |
98 | MP0004947_skin_inflammation | 0.92714014 |
99 | MP0003635_abnormal_synaptic_transmissio | 0.92539387 |
100 | MP0002139_abnormal_hepatobiliary_system | 0.92510875 |
101 | MP0005387_immune_system_phenotype | 0.91686011 |
102 | MP0001790_abnormal_immune_system | 0.91686011 |
103 | MP0000343_altered_response_to | 0.90286383 |
104 | MP0003111_abnormal_nucleus_morphology | 0.89664043 |
105 | MP0000367_abnormal_coat/_hair | 0.89028442 |
106 | MP0004484_altered_response_of | 0.87049028 |
107 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.86545045 |
108 | MP0003448_altered_tumor_morphology | 0.86297229 |
109 | MP0000716_abnormal_immune_system | 0.85982783 |
110 | MP0006072_abnormal_retinal_apoptosis | 0.85793267 |
111 | MP0001879_abnormal_lymphatic_vessel | 0.85677417 |
112 | MP0002019_abnormal_tumor_incidence | 0.84933732 |
113 | MP0009643_abnormal_urine_homeostasis | 0.84512593 |
114 | MP0002254_reproductive_system_inflammat | 0.84231911 |
115 | MP0003632_abnormal_nervous_system | 0.82998534 |
116 | MP0010329_abnormal_lipoprotein_level | 0.82766743 |
117 | MP0001501_abnormal_sleep_pattern | 0.82268150 |
118 | MP0003935_abnormal_craniofacial_develop | 0.82256755 |
119 | MP0001664_abnormal_digestion | 0.82048493 |
120 | MP0005000_abnormal_immune_tolerance | 0.81850272 |
121 | MP0002429_abnormal_blood_cell | 0.80847446 |
122 | MP0002075_abnormal_coat/hair_pigmentati | 0.79843490 |
123 | MP0003303_peritoneal_inflammation | 0.79539488 |
124 | MP0002136_abnormal_kidney_physiology | 0.79003471 |
125 | MP0003122_maternal_imprinting | 0.78886095 |
126 | MP0005385_cardiovascular_system_phenoty | 0.77006225 |
127 | MP0001544_abnormal_cardiovascular_syste | 0.77006225 |
128 | MP0000569_abnormal_digit_pigmentation | 0.76587328 |
129 | MP0009333_abnormal_splenocyte_physiolog | 0.76586752 |
130 | MP0005389_reproductive_system_phenotype | 0.76381750 |
131 | MP0004134_abnormal_chest_morphology | 0.76198186 |
132 | MP0002735_abnormal_chemical_nociception | 0.75875150 |
133 | MP0002166_altered_tumor_susceptibility | 0.75849164 |
134 | MP0002148_abnormal_hypersensitivity_rea | 0.75808173 |
135 | MP0003183_abnormal_peptide_metabolism | 0.75205544 |
136 | MP0001851_eye_inflammation | 0.73794718 |
137 | MP0001958_emphysema | 0.73537565 |
138 | MP0010307_abnormal_tumor_latency | 0.73422416 |
139 | MP0005623_abnormal_meninges_morphology | 0.73353518 |
140 | MP0000689_abnormal_spleen_morphology | 0.72283896 |
141 | MP0000371_diluted_coat_color | 0.72122805 |
142 | MP0004043_abnormal_pH_regulation | 0.71688174 |
143 | MP0001845_abnormal_inflammatory_respons | 0.71455245 |
144 | MP0002405_respiratory_system_inflammati | 0.71430402 |
145 | MP0003077_abnormal_cell_cycle | 0.71417034 |
146 | MP0005330_cardiomyopathy | 0.71062868 |
147 | MP0001545_abnormal_hematopoietic_system | 0.69810082 |
148 | MP0005397_hematopoietic_system_phenotyp | 0.69810082 |
149 | MP0002722_abnormal_immune_system | 0.69672168 |
150 | MP0008469_abnormal_protein_level | 0.69584473 |
151 | MP0000747_muscle_weakness | 0.69361938 |
152 | MP0001191_abnormal_skin_condition | 0.68910325 |
153 | MP0009931_abnormal_skin_appearance | 0.68699941 |
154 | MP0002736_abnormal_nociception_after | 0.67938792 |
155 | MP0002106_abnormal_muscle_physiology | 0.66971628 |
156 | MP0001324_abnormal_eye_pigmentation | 0.66390947 |
157 | MP0010630_abnormal_cardiac_muscle | 0.66252672 |
158 | MP0000490_abnormal_crypts_of | 0.65549331 |
159 | MP0002067_abnormal_sensory_capabilities | 0.65347287 |
160 | MP0002060_abnormal_skin_morphology | 0.65218143 |
161 | MP0005248_abnormal_Harderian_gland | 0.64737298 |
162 | MP0003315_abnormal_perineum_morphology | 0.63579094 |
163 | MP0006138_congestive_heart_failure | 0.63256037 |
164 | MP0005085_abnormal_gallbladder_physiolo | 0.62321385 |
165 | MP0002882_abnormal_neuron_morphology | 0.61634384 |
166 | MP0000579_abnormal_nail_morphology | 0.61599874 |
167 | MP0002972_abnormal_cardiac_muscle | 0.61313192 |
168 | MP0000858_altered_metastatic_potential | 0.60985294 |
169 | MP0002572_abnormal_emotion/affect_behav | 0.58019726 |
170 | MP0001614_abnormal_blood_vessel | 0.57780317 |
171 | MP0000427_abnormal_hair_cycle | 0.57566712 |
172 | MP0002128_abnormal_blood_circulation | 0.56932622 |
173 | MP0001915_intracranial_hemorrhage | 0.56197706 |
174 | MP0000733_abnormal_muscle_development | 0.55963177 |
175 | MP0005023_abnormal_wound_healing | 0.53832722 |
176 | MP0002925_abnormal_cardiovascular_devel | 0.53604333 |
177 | MP0005369_muscle_phenotype | 0.53598845 |
178 | MP0002272_abnormal_nervous_system | 0.52227658 |
179 | MP0008872_abnormal_physiological_respon | 0.51894756 |
180 | MP0003861_abnormal_nervous_system | 0.50411286 |
181 | MP0000383_abnormal_hair_follicle | 0.50172828 |
182 | MP0000534_abnormal_ureter_morphology | 0.48820301 |
183 | MP0000681_abnormal_thyroid_gland | 0.48364744 |
184 | MP0005670_abnormal_white_adipose | 0.48323165 |
185 | MP0000432_abnormal_head_morphology | 0.47555839 |
186 | MP0003567_abnormal_fetal_cardiomyocyte | 0.47472244 |
187 | MP0002069_abnormal_eating/drinking_beha | 0.46922909 |
188 | MP0005253_abnormal_eye_physiology | 0.46030313 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Cervical subluxation (HP:0003308) | 8.48534076 |
2 | Overgrowth (HP:0001548) | 7.55612698 |
3 | Vacuolated lymphocytes (HP:0001922) | 6.84462374 |
4 | Abnormality of dental color (HP:0011073) | 6.84267414 |
5 | Ulnar deviation of the wrist (HP:0003049) | 6.81233242 |
6 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 6.45910508 |
7 | Vertebral hypoplasia (HP:0008417) | 6.45910508 |
8 | Testicular atrophy (HP:0000029) | 5.97892018 |
9 | Dyschromatopsia (HP:0007641) | 5.95563873 |
10 | Rib fusion (HP:0000902) | 5.86384095 |
11 | Neoplasm of the adrenal cortex (HP:0100641) | 5.54879806 |
12 | Hemorrhage of the eye (HP:0011885) | 5.32854168 |
13 | Attenuation of retinal blood vessels (HP:0007843) | 5.16602321 |
14 | Rectal fistula (HP:0100590) | 5.14708268 |
15 | Rectovaginal fistula (HP:0000143) | 5.14708268 |
16 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 5.14461179 |
17 | Thin bony cortex (HP:0002753) | 4.98125532 |
18 | Intestinal fistula (HP:0100819) | 4.97959075 |
19 | Growth hormone excess (HP:0000845) | 4.96950720 |
20 | Mesangial abnormality (HP:0001966) | 4.94484972 |
21 | Upper limb muscle weakness (HP:0003484) | 4.90754824 |
22 | Amelogenesis imperfecta (HP:0000705) | 4.89812901 |
23 | Joint hemorrhage (HP:0005261) | 4.86816335 |
24 | Flared iliac wings (HP:0002869) | 4.78742550 |
25 | Vaginal fistula (HP:0004320) | 4.72187629 |
26 | Back pain (HP:0003418) | 4.66836385 |
27 | Poikiloderma (HP:0001029) | 4.61014836 |
28 | Facial diplegia (HP:0001349) | 4.60227196 |
29 | Prolonged partial thromboplastin time (HP:0003645) | 4.50361555 |
30 | Annular pancreas (HP:0001734) | 4.42478079 |
31 | Choroideremia (HP:0001139) | 4.39842043 |
32 | Facial hemangioma (HP:0000329) | 4.30296878 |
33 | Beaking of vertebral bodies (HP:0004568) | 4.20107483 |
34 | Abnormality of the intrinsic pathway (HP:0010989) | 4.18522423 |
35 | Popliteal pterygium (HP:0009756) | 4.15365452 |
36 | Abnormality of the parathyroid morphology (HP:0011766) | 4.10638477 |
37 | Akinesia (HP:0002304) | 4.08005313 |
38 | Ulnar bowing (HP:0003031) | 3.99726031 |
39 | Abnormality of renal resorption (HP:0011038) | 3.88730341 |
40 | Short 1st metacarpal (HP:0010034) | 3.69987549 |
41 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 3.69987549 |
42 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.67501404 |
43 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.62832674 |
44 | Mucopolysacchariduria (HP:0008155) | 3.62832674 |
45 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 3.62407708 |
46 | Pelvic girdle muscle weakness (HP:0003749) | 3.58564860 |
47 | Increased hepatocellular lipid droplets (HP:0006565) | 3.55342693 |
48 | Aplasia of the musculature (HP:0100854) | 3.54756561 |
49 | Hypoplasia of the odontoid process (HP:0003311) | 3.52607879 |
50 | Shoulder girdle muscle weakness (HP:0003547) | 3.51697002 |
51 | Disproportionate short-trunk short stature (HP:0003521) | 3.49747600 |
52 | Widely spaced teeth (HP:0000687) | 3.49134411 |
53 | Renal Fanconi syndrome (HP:0001994) | 3.47338959 |
54 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.42999789 |
55 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.42999789 |
56 | Lipid accumulation in hepatocytes (HP:0006561) | 3.42702365 |
57 | Limb-girdle muscle atrophy (HP:0003797) | 3.39548892 |
58 | Anteriorly placed anus (HP:0001545) | 3.37222580 |
59 | Enlarged epiphyses (HP:0010580) | 3.33880026 |
60 | Squamous cell carcinoma (HP:0002860) | 3.32750075 |
61 | Scapular winging (HP:0003691) | 3.32048218 |
62 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.29915916 |
63 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.29915916 |
64 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.29915916 |
65 | Abnormality of the dental pulp (HP:0006479) | 3.29282205 |
66 | Delayed epiphyseal ossification (HP:0002663) | 3.28088450 |
67 | Congenital stationary night blindness (HP:0007642) | 3.27506564 |
68 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.27167599 |
69 | Myokymia (HP:0002411) | 3.25847210 |
70 | Abnormality of the 1st metacarpal (HP:0010009) | 3.21785270 |
71 | Difficulty climbing stairs (HP:0003551) | 3.19207436 |
72 | Hypercortisolism (HP:0001578) | 3.18315908 |
73 | Abnormality of the hip-girdle musculature (HP:0001445) | 3.17106884 |
74 | Abnormality of the musculature of the pelvis (HP:0001469) | 3.17106884 |
75 | Decreased central vision (HP:0007663) | 3.13666746 |
76 | Bony spicule pigmentary retinopathy (HP:0007737) | 3.13092879 |
77 | Fetal akinesia sequence (HP:0001989) | 3.11801577 |
78 | Hypoalbuminemia (HP:0003073) | 3.11269614 |
79 | Abnormal albumin level (HP:0012116) | 3.11269614 |
80 | Turricephaly (HP:0000262) | 3.10653801 |
81 | Capillary hemangiomas (HP:0005306) | 3.08827353 |
82 | Exertional dyspnea (HP:0002875) | 3.08180770 |
83 | Abnormality of the common coagulation pathway (HP:0010990) | 3.05949826 |
84 | Gingival overgrowth (HP:0000212) | 3.05468272 |
85 | Polyuria (HP:0000103) | 3.04532212 |
86 | Abnormality of the odontoid process (HP:0003310) | 3.03779261 |
87 | Short chin (HP:0000331) | 2.98575021 |
88 | Rimmed vacuoles (HP:0003805) | 2.97280043 |
89 | Abnormality of macrophages (HP:0004311) | 2.95124137 |
90 | Ovoid vertebral bodies (HP:0003300) | 2.93255241 |
91 | Abnormality of the costochondral junction (HP:0000919) | 2.90867363 |
92 | Abnormality of placental membranes (HP:0011409) | 2.90422412 |
93 | Amniotic constriction ring (HP:0009775) | 2.90422412 |
94 | Atrioventricular block (HP:0001678) | 2.83666715 |
95 | Abnormal urine output (HP:0012590) | 2.80282275 |
96 | Coronal craniosynostosis (HP:0004440) | 2.79305854 |
97 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.75483724 |
98 | Severe short stature (HP:0003510) | 2.75263174 |
99 | Patellar aplasia (HP:0006443) | 2.74192327 |
100 | Chorioretinal atrophy (HP:0000533) | 2.74167484 |
101 | Myotonia (HP:0002486) | 2.73293278 |
102 | Hypophosphatemic rickets (HP:0004912) | 2.66748707 |
103 | Widely patent fontanelles and sutures (HP:0004492) | 2.66635062 |
104 | Abnormal sex determination (HP:0012244) | 2.66487705 |
105 | Sex reversal (HP:0012245) | 2.66487705 |
106 | Fused cervical vertebrae (HP:0002949) | 2.64583674 |
107 | Generalized myoclonic seizures (HP:0002123) | 2.58528114 |
108 | Aortic valve stenosis (HP:0001650) | 2.57356862 |
109 | Hyperparathyroidism (HP:0000843) | 2.55628067 |
110 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.54430885 |
111 | Zonular cataract (HP:0010920) | 2.54177991 |
112 | Abnormal auditory evoked potentials (HP:0006958) | 2.52738964 |
113 | Increased intramyocellular lipid droplets (HP:0012240) | 2.49731692 |
114 | Increased muscle lipid content (HP:0009058) | 2.48647670 |
115 | Cheilitis (HP:0100825) | 2.47570520 |
116 | Exocrine pancreatic insufficiency (HP:0001738) | 2.41468108 |
117 | Neonatal respiratory distress (HP:0002643) | 2.40937624 |
118 | Progressive neurologic deterioration (HP:0002344) | 2.39884117 |
119 | Premature graying of hair (HP:0002216) | 2.37940054 |
120 | Basal cell carcinoma (HP:0002671) | 2.37795992 |
121 | Mask-like facies (HP:0000298) | 2.34593645 |
122 | Respiratory difficulties (HP:0002880) | 2.33459180 |
123 | Abnormality of renal excretion (HP:0011036) | 2.32993471 |
124 | Shallow orbits (HP:0000586) | 2.31722980 |
125 | Gastrointestinal infarctions (HP:0005244) | 2.30140669 |
126 | Bowing of the arm (HP:0006488) | 2.28367811 |
127 | Bowed forearm bones (HP:0003956) | 2.28367811 |
128 | Abnormality of the hepatic vasculature (HP:0006707) | 2.28293241 |
129 | Neonatal onset (HP:0003623) | 2.24538003 |
130 | Absent thumb (HP:0009777) | 2.24390117 |
131 | Neoplasm of the adrenal gland (HP:0100631) | 2.21964234 |
132 | Flat occiput (HP:0005469) | 2.20924551 |
133 | Vitreoretinal degeneration (HP:0000655) | 2.20814589 |
134 | Short humerus (HP:0005792) | 2.20246173 |
135 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.20092808 |
136 | Recurrent cutaneous fungal infections (HP:0011370) | 2.20092808 |
137 | Short phalanx of the thumb (HP:0009660) | 2.19512841 |
138 | Nephrocalcinosis (HP:0000121) | 2.19340126 |
139 | Anosmia (HP:0000458) | 2.15756517 |
140 | Abnormal epiphyseal ossification (HP:0010656) | 2.14505934 |
141 | Limb-girdle muscle weakness (HP:0003325) | 2.14002676 |
142 | Hyperpituitarism (HP:0010514) | 2.13365402 |
143 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.11978236 |
144 | Abnormal urine phosphate concentration (HP:0012599) | 2.11627905 |
145 | Malignant hyperthermia (HP:0002047) | 2.11233991 |
146 | Spinal rigidity (HP:0003306) | 2.10762011 |
147 | Acute necrotizing encephalopathy (HP:0006965) | 2.08177460 |
148 | Increased number of teeth (HP:0011069) | 2.08151178 |
149 | Coxa valga (HP:0002673) | 2.06719045 |
150 | Hallux valgus (HP:0001822) | 2.06247670 |
151 | Restrictive lung disease (HP:0002091) | 2.03809887 |
152 | Long clavicles (HP:0000890) | 2.02365389 |
153 | Aplasia/Hypoplasia involving the vertebral column (HP:0008518) | 2.01189380 |
154 | Proximal amyotrophy (HP:0007126) | 2.00336653 |
155 | Onion bulb formation (HP:0003383) | 1.98070658 |
156 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.97416041 |
157 | Cystic hygroma (HP:0000476) | 1.97291642 |
158 | Macular degeneration (HP:0000608) | 1.96619908 |
159 | Multiple enchondromatosis (HP:0005701) | 1.96268470 |
160 | Narrow nasal bridge (HP:0000446) | 1.95842760 |
161 | Joint stiffness (HP:0001387) | 1.93448098 |
162 | Multiple lipomas (HP:0001012) | 1.93290152 |
163 | Pustule (HP:0200039) | 1.90894696 |
164 | Deviation of the hallux (HP:0010051) | 1.89682656 |
165 | Severe Myopia (HP:0011003) | 1.89048660 |
166 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.88394475 |
167 | Decreased circulating renin level (HP:0003351) | 1.87555899 |
168 | Ankle contracture (HP:0006466) | 1.86221783 |
169 | Epiphyseal stippling (HP:0010655) | 1.85929802 |
170 | Thin ribs (HP:0000883) | 1.85884576 |
171 | Epistaxis (HP:0000421) | 1.84857538 |
172 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.83989122 |
173 | Polydipsia (HP:0001959) | 1.83444827 |
174 | Abnormal drinking behavior (HP:0030082) | 1.83444827 |
175 | Difficulty walking (HP:0002355) | 1.80656991 |
176 | Choanal stenosis (HP:0000452) | 1.80630727 |
177 | Premature rupture of membranes (HP:0001788) | 1.80248969 |
178 | Peripheral demyelination (HP:0011096) | 1.79853180 |
179 | Abnormality of subcutaneous fat tissue (HP:0001001) | 1.79580545 |
180 | Progressive macrocephaly (HP:0004481) | 1.76759541 |
181 | Fasciculations (HP:0002380) | 1.74176883 |
182 | Termporal pattern (HP:0011008) | 1.73668067 |
183 | Insidious onset (HP:0003587) | 1.73668067 |
184 | Short hallux (HP:0010109) | 1.72689448 |
185 | Sensory axonal neuropathy (HP:0003390) | 1.70451687 |
186 | Aqueductal stenosis (HP:0002410) | 1.69587807 |
187 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.69179173 |
188 | Glossoptosis (HP:0000162) | 1.68583234 |
189 | Conjugated hyperbilirubinemia (HP:0002908) | 1.66128933 |
190 | Abnormality of the acetabulum (HP:0003170) | 1.62226259 |
191 | Acute encephalopathy (HP:0006846) | 1.60758316 |
192 | Adenoma sebaceum (HP:0009720) | 1.60158259 |
193 | Angiofibromas (HP:0010615) | 1.60158259 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BLK | 3.97791785 |
2 | MAP3K3 | 3.38313130 |
3 | WNK4 | 3.23142407 |
4 | ERBB2 | 2.76721321 |
5 | MAP2K7 | 2.73728096 |
6 | PRKD3 | 2.52244921 |
7 | MAP2K4 | 2.49690968 |
8 | EPHB1 | 2.48837441 |
9 | MUSK | 2.46222347 |
10 | ZAP70 | 2.39035182 |
11 | MAP3K4 | 2.33805071 |
12 | MAP2K3 | 2.32995215 |
13 | MAP4K1 | 2.19066809 |
14 | MAP2K2 | 2.16200912 |
15 | MAPK7 | 2.12528199 |
16 | ACVR1B | 2.06921066 |
17 | CCNB1 | 12.2422710 |
18 | TLK1 | 1.87982378 |
19 | IRAK2 | 1.66204236 |
20 | DYRK1A | 1.63521544 |
21 | TRPM7 | 1.63071565 |
22 | TRIB3 | 1.59705545 |
23 | WNK1 | 1.45793456 |
24 | IRAK4 | 1.41906315 |
25 | CDK6 | 1.40016973 |
26 | NME1 | 1.35364895 |
27 | MAPK4 | 1.34172793 |
28 | INSRR | 1.31145420 |
29 | PDPK1 | 1.29456361 |
30 | PTK6 | 1.29010701 |
31 | CDK12 | 1.27527569 |
32 | CDK4 | 1.26014775 |
33 | PRPF4B | 1.25505586 |
34 | MKNK2 | 1.23578059 |
35 | RIPK4 | 1.22863931 |
36 | BTK | 1.22344007 |
37 | TESK2 | 1.21374273 |
38 | SIK1 | 1.20304952 |
39 | DYRK1B | 1.18981732 |
40 | TBK1 | 1.18011498 |
41 | TAOK3 | 1.17557590 |
42 | IKBKE | 1.06836683 |
43 | MST1R | 1.06014281 |
44 | SYK | 1.03459230 |
45 | MAP3K10 | 1.02806033 |
46 | SIK2 | 1.02705658 |
47 | EPHB2 | 1.00527823 |
48 | PIK3CG | 0.97122941 |
49 | ADRBK1 | 0.95841258 |
50 | SIK3 | 0.94914840 |
51 | FES | 0.93485157 |
52 | JAK3 | 0.92636035 |
53 | SGK2 | 0.92534199 |
54 | PTK2B | 0.92371164 |
55 | ICK | 0.92324505 |
56 | NME2 | 0.91755277 |
57 | DMPK | 0.88924514 |
58 | LYN | 0.88173944 |
59 | BMX | 0.88045961 |
60 | MAPK11 | 0.87477769 |
61 | ADRBK2 | 0.86744668 |
62 | CAMK1D | 0.86688910 |
63 | GSK3A | 0.85252708 |
64 | MAPK12 | 0.84485539 |
65 | RET | 0.83237216 |
66 | ITK | 0.81139258 |
67 | MAPK9 | 0.78132846 |
68 | GRK5 | 0.77868446 |
69 | CAMKK2 | 0.77862524 |
70 | SGK223 | 0.77493671 |
71 | SGK494 | 0.77493671 |
72 | MAP3K7 | 0.76472388 |
73 | CAMK1G | 0.75566621 |
74 | PRKD2 | 0.73368651 |
75 | TRIM28 | 0.72738138 |
76 | NEK9 | 0.72002083 |
77 | RPS6KA2 | 0.70882349 |
78 | MARK2 | 0.69962897 |
79 | BMPR2 | 0.69865680 |
80 | NTRK2 | 0.68970062 |
81 | MAP3K2 | 0.65747258 |
82 | CSF1R | 0.65633143 |
83 | TXK | 0.65597829 |
84 | ERN1 | 0.65496865 |
85 | NLK | 0.63794298 |
86 | MKNK1 | 0.62729070 |
87 | RPS6KA6 | 0.62462887 |
88 | HCK | 0.62162734 |
89 | OXSR1 | 0.61857383 |
90 | PAK3 | 0.60785217 |
91 | LCK | 0.60113473 |
92 | MELK | 0.59896362 |
93 | ZAK | 0.58636777 |
94 | TEC | 0.58624687 |
95 | EPHA2 | 0.58179512 |
96 | CAMK4 | 0.58049826 |
97 | TGFBR2 | 0.57329815 |
98 | MARK1 | 0.57103804 |
99 | SGK3 | 0.56717232 |
100 | TYK2 | 0.56503593 |
101 | TTN | 0.55415271 |
102 | UHMK1 | 0.54939576 |
103 | PTK2 | 0.54323481 |
104 | RPS6KC1 | 0.53815381 |
105 | RPS6KL1 | 0.53815381 |
106 | PAK4 | 0.53249164 |
107 | MAP3K13 | 0.52810068 |
108 | PRKD1 | 0.52004034 |
109 | KIT | 0.51942265 |
110 | MAPKAPK3 | 0.51524118 |
111 | PDK1 | 0.51087492 |
112 | EPHA3 | 0.50554656 |
113 | MTOR | 0.48916066 |
114 | STK39 | 0.48538626 |
115 | ALK | 0.48477357 |
116 | STK11 | 0.48432177 |
117 | FGFR4 | 0.46518503 |
118 | CDK15 | 0.46418038 |
119 | SCYL2 | 0.45908149 |
120 | FLT3 | 0.45188359 |
121 | IKBKB | 0.44791545 |
122 | CDK18 | 0.42979753 |
123 | CHUK | 0.42854581 |
124 | RPS6KA5 | 0.42725452 |
125 | MAPK8 | 0.42626863 |
126 | CSK | 0.41598723 |
127 | CDC42BPA | 0.40795704 |
128 | MAP3K1 | 0.39997429 |
129 | CDK11A | 0.39642976 |
130 | GRK7 | 0.39466966 |
131 | CHEK2 | 0.39267656 |
132 | ABL1 | 0.38504557 |
133 | STK10 | 0.37901901 |
134 | PKN2 | 0.37187343 |
135 | AKT3 | 0.34689189 |
136 | MAP2K1 | 0.34533387 |
137 | FGFR2 | 0.34076254 |
138 | IRAK3 | 0.33986663 |
139 | IRAK1 | 0.32874721 |
140 | JAK1 | 0.32596752 |
141 | AURKA | 0.31969672 |
142 | CDK5 | 0.31408305 |
143 | MAP3K11 | 0.31121900 |
144 | HIPK2 | 0.31114783 |
145 | FYN | 0.31065346 |
146 | FGFR3 | 0.30393800 |
147 | GRK6 | 0.30366834 |
148 | IGF1R | 0.29047574 |
149 | CAMK1 | 0.28565892 |
150 | TIE1 | 0.26557811 |
151 | RIPK1 | 0.25549761 |
152 | MAP2K6 | 0.25513109 |
153 | PAK6 | 0.25277178 |
154 | CSNK1A1 | 0.24642291 |
155 | GSK3B | 0.24182519 |
156 | PAK2 | 0.23791714 |
157 | ERBB3 | 0.22578619 |
158 | JAK2 | 0.21173060 |
159 | MAPK10 | 0.20684716 |
160 | PAK1 | 0.19858881 |
161 | MAPK1 | 0.19851027 |
162 | MAP3K14 | 0.19749629 |
163 | LRRK2 | 0.19739927 |
164 | NTRK3 | 0.19459689 |
165 | NTRK1 | 0.18730260 |
166 | MAPKAPK2 | 0.17849161 |
167 | ATM | 0.17414086 |
168 | MAPK15 | 0.16627631 |
169 | MOS | 0.16120886 |
170 | CAMKK1 | 0.16024681 |
171 | FRK | 0.15993604 |
172 | PKN1 | 0.15430126 |
173 | CSNK1G1 | 0.15392757 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 5.90417487 |
2 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 5.73225854 |
3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 4.78033429 |
4 | Other glycan degradation_Homo sapiens_hsa00511 | 4.64301957 |
5 | Sulfur relay system_Homo sapiens_hsa04122 | 3.13945776 |
6 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.03388832 |
7 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.52958121 |
8 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.38024427 |
9 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.29327304 |
10 | Wnt signaling pathway_Homo sapiens_hsa04310 | 2.19844416 |
11 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.15521278 |
12 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.11775684 |
13 | Galactose metabolism_Homo sapiens_hsa00052 | 2.07648750 |
14 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.94188013 |
15 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.78467581 |
16 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.71674557 |
17 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.69738044 |
18 | Circadian rhythm_Homo sapiens_hsa04710 | 1.67207187 |
19 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.55606678 |
20 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.36213745 |
21 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.31501866 |
22 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.30126901 |
23 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.29653566 |
24 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.27797214 |
25 | Viral myocarditis_Homo sapiens_hsa05416 | 1.27763028 |
26 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.27123486 |
27 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.24181246 |
28 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.23067034 |
29 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.22122044 |
30 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.20942867 |
31 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.20647720 |
32 | Adherens junction_Homo sapiens_hsa04520 | 1.15501161 |
33 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.11476546 |
34 | Prion diseases_Homo sapiens_hsa05020 | 1.10883791 |
35 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.10860036 |
36 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.10734408 |
37 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.08377275 |
38 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.07277844 |
39 | Tuberculosis_Homo sapiens_hsa05152 | 1.05697615 |
40 | Pertussis_Homo sapiens_hsa05133 | 1.04310566 |
41 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.03349577 |
42 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.03287622 |
43 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.00893523 |
44 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.00066527 |
45 | Lysosome_Homo sapiens_hsa04142 | 1.00039351 |
46 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.99896571 |
47 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.98554992 |
48 | Axon guidance_Homo sapiens_hsa04360 | 0.98301453 |
49 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.98198331 |
50 | Leishmaniasis_Homo sapiens_hsa05140 | 0.97878079 |
51 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.94478242 |
52 | Nicotine addiction_Homo sapiens_hsa05033 | 0.94191299 |
53 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.93631461 |
54 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.93345220 |
55 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.92273626 |
56 | Insulin resistance_Homo sapiens_hsa04931 | 0.92188825 |
57 | Circadian entrainment_Homo sapiens_hsa04713 | 0.91791473 |
58 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.91518111 |
59 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.91154042 |
60 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.90327152 |
61 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.89945747 |
62 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.89810367 |
63 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.89293599 |
64 | Asthma_Homo sapiens_hsa05310 | 0.88716965 |
65 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.88618208 |
66 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.88391383 |
67 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.87414131 |
68 | Influenza A_Homo sapiens_hsa05164 | 0.86562413 |
69 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.86361323 |
70 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.86108745 |
71 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.86073906 |
72 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.85828045 |
73 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.85679135 |
74 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.85388147 |
75 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.84788731 |
76 | Allograft rejection_Homo sapiens_hsa05330 | 0.82596646 |
77 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.82273134 |
78 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.82243786 |
79 | Focal adhesion_Homo sapiens_hsa04510 | 0.81529057 |
80 | Bladder cancer_Homo sapiens_hsa05219 | 0.80459431 |
81 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.80445332 |
82 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.78592114 |
83 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.77135492 |
84 | Melanogenesis_Homo sapiens_hsa04916 | 0.77085910 |
85 | Insulin secretion_Homo sapiens_hsa04911 | 0.76664503 |
86 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.75672736 |
87 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.75029743 |
88 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.74805152 |
89 | Salivary secretion_Homo sapiens_hsa04970 | 0.74597279 |
90 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.74061525 |
91 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.73900544 |
92 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.72677952 |
93 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.72445206 |
94 | Taste transduction_Homo sapiens_hsa04742 | 0.72407934 |
95 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.72005399 |
96 | Amoebiasis_Homo sapiens_hsa05146 | 0.71205772 |
97 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.70150253 |
98 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.68856539 |
99 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.68795213 |
100 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.68535667 |
101 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.67498271 |
102 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.67489686 |
103 | Colorectal cancer_Homo sapiens_hsa05210 | 0.67014307 |
104 | Renin secretion_Homo sapiens_hsa04924 | 0.66907102 |
105 | Gap junction_Homo sapiens_hsa04540 | 0.66764315 |
106 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.66743142 |
107 | Bile secretion_Homo sapiens_hsa04976 | 0.66595273 |
108 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.65361951 |
109 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.64950429 |
110 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.64205778 |
111 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.63360277 |
112 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.63177339 |
113 | Salmonella infection_Homo sapiens_hsa05132 | 0.62950201 |
114 | Alcoholism_Homo sapiens_hsa05034 | 0.62629556 |
115 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.62585173 |
116 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.61595695 |
117 | GABAergic synapse_Homo sapiens_hsa04727 | 0.61545046 |
118 | Hepatitis C_Homo sapiens_hsa05160 | 0.61388205 |
119 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.61096355 |
120 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.60751096 |
121 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.60548831 |
122 | Long-term potentiation_Homo sapiens_hsa04720 | 0.60520968 |
123 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.60310592 |
124 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.59028485 |
125 | Hepatitis B_Homo sapiens_hsa05161 | 0.58919792 |
126 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.58453560 |
127 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.56562308 |
128 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.55524801 |
129 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.54390450 |
130 | Endocytosis_Homo sapiens_hsa04144 | 0.54354692 |
131 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.51863517 |
132 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.51481635 |
133 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.51177139 |
134 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.50548611 |
135 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.50360153 |
136 | Cocaine addiction_Homo sapiens_hsa05030 | 0.49911541 |
137 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.49896701 |
138 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.49205198 |
139 | Measles_Homo sapiens_hsa05162 | 0.48522143 |
140 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.48447383 |
141 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.48421474 |
142 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.47558309 |
143 | Phototransduction_Homo sapiens_hsa04744 | 0.47278720 |
144 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.47206831 |
145 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.47049668 |
146 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.45850537 |
147 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.45171800 |
148 | Platelet activation_Homo sapiens_hsa04611 | 0.43240152 |
149 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.43133909 |
150 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.41882591 |
151 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.41761286 |
152 | Pathways in cancer_Homo sapiens_hsa05200 | 0.40631776 |
153 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.40307849 |
154 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.39982366 |
155 | Apoptosis_Homo sapiens_hsa04210 | 0.39159113 |
156 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.38382841 |
157 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.38273513 |
158 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.38165059 |
159 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.37934241 |
160 | Morphine addiction_Homo sapiens_hsa05032 | 0.37352429 |
161 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.36948097 |
162 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.36771107 |
163 | Long-term depression_Homo sapiens_hsa04730 | 0.35581007 |
164 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.35045312 |
165 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.34271960 |
166 | Lysine degradation_Homo sapiens_hsa00310 | 0.34138256 |
167 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.33094169 |
168 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.32801812 |
169 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.32711926 |
170 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.32235927 |
171 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.31901099 |
172 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.31848094 |
173 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.31478868 |
174 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.30861877 |
175 | Endometrial cancer_Homo sapiens_hsa05213 | 0.30800612 |
176 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.30318195 |
177 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.27619558 |
178 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.26285517 |